BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ProSensa Holding N.V. Announces Commencement Of Re-Dosing Of Drisapersen In North America In Patients With Duchenne Muscular Dystrophy

  September 18, 2014

   · 

  8 min read
• Business

  Five Prime Therapeutics, Inc. Appoints Dr. Robert Sikorski As Vice President Of Global Clinical Development

  September 18, 2014

   · 

  2 min read
• Drug Development

  Rebiotix Release: PUNCH CD Study Drug Targeting Recurrent C. Difficile Infection To Be Presented At IDWeek 2014

  September 18, 2014

   · 

  4 min read
• Genetown

  Cerulean Pharma Inc. To Present At Biocentury’s Newsmakers In Biotechnology Conference

  September 18, 2014

   · 

  1 min read
• Can-Fite BioPharma Files June 30, 2014 Interim Financial Statements

  September 18, 2014

   · 

  3 min read
• BioForest

  Oncothyreon Inc. Announces Proposed Public Offerings

  September 18, 2014

   · 

  3 min read
• Biotech Bay

  Elekta Release: Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable

  September 18, 2014

   · 

  4 min read
• Information Update - Health Canada Requests Quarantine Of Products From Ipca Laboratories Following Falsification And Manipulation Of Data Issues

  September 18, 2014

   · 

  1 min read
• Drug Development

  Immune Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial In Ulcerative Colitis

  September 18, 2014

   · 

  5 min read
• Biotech Bay

  Acclarent, Inc. Launches Minimally-Invasive ACCLARENT AERA™ Eustachian Tube Balloon Dilation System In Europe

  September 18, 2014

   · 

  4 min read